| Literature DB >> 32652996 |
Elena Krachmarova1, Ivan Ivanov1, Genoveva Nacheva2.
Abstract
BACKGROUND: Inclusion bodies (IBs) are protein aggregates in recombinant bacterial cells containing mainly the target recombinant protein. Although it has been shown that IBs contain functional proteins along with protein aggregates, their direct application as pharmaceuticals is hindered by their heterogeneity and hazardous contaminants with bacterial origin. Therefore, together with the production of soluble species, IBs remain the main source for manufacture of recombinant proteins with medical application. The quality and composition of the IBs affect the refolding yield and further purification of the recombinant protein. The knowledge whether nucleic acids are genuine components or concomitant impurities of the IBs is a prerequisite for the understanding of the IBs formation and for development of optimized protocols for recombinant protein refolding and purification. IBs isolated from Escherichia coli overexpressing human interferon-gamma (hIFNγ), a protein with therapeutic application, were used as a model.Entities:
Keywords: E. coli; Human interferon-gamma; Inclusion bodies; Nucleic acids; Protein aggregation; Recombinant protein production
Mesh:
Substances:
Year: 2020 PMID: 32652996 PMCID: PMC7353671 DOI: 10.1186/s12934-020-01400-6
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Schematic illustration showing the IBs purification steps and analysis for presence of viable bacterial cells
Fig. 2SDS PAGE electrophoretic pattern of hIFNγ IBs. 1—Purified hIFNγ obtained as described in [41] was used as a standard, the molecular weight of the monomer and the covalently bound dimer and tetramer are shown in kDa; 2—Crude IBs; 3—IBs after the last purification step 3
Fig. 3a Agarose gel-electrophoresis of nucleic acids isolated from purified hIFNγ IBs. 1—Sample, isolated from IBs, b Agarose gel-electrophoresis of nucleic acids isolated from purified hIFNγ IBs treated with restriction endonuclease XhoI and c HindIII. 1—Non-treated sample; 2(b)—Sample treated with XhoI; 2(c)—sample treated with HindIII; d Enzymatic digestion of nucleic acids isolated from purified hIFNγ IBs 1—non treated sample; 2—sample treated with mixture of RNase A and RNase T1; 3—sample treated with DNase I; 4—sample treated with Proteinase K; M—Molecular weight marker, bp
Fig. 4a Agarose gel-electrophoresis of RNA, isolated from purified hIFNγ IBs. 1—RNA, isolated from purified hIFNγ IBs; 2—total RNA, isolated from non-transformed E. coli cells. b, c Dot-blot hybridization of RNA isolated from hIFNγ IBs. b RNA was dotted on nitrocellulose filters, hybridized with 32P-labelled oligonucleotide specific for hIFNγ mRNA, striped and c reprobed with oligonucleotide specific for the E. coli 16S rRNA. Total amount of RNA on the dots: A1 and A2—10 µg; B1 and B2—5 µg; C1 and C2—2.5 µg; D1 and D2—1 µg; A3—10 µg RNA pre-treated with DNase; B3—10 µg total RNA isolated from transformed E. coli cells; C3 and D3—10 µg total RNA isolated from non-transformed E. coli cells